Antimicrobial Regenerative Wound Matrix Market Analysis with Top Key-Players: 3M, Turn Therapeutics, DSM Biomedical, H&R Healthcare Ltd, Harbor Medtech Inc. 2022-2031

Antimicrobial Regenerative Wound Matrix is a very important part of the wound care industry and global trade. Antimicrobial Regenerative Wound matrix is used to improve the regeneration of dermal and epidermal layers in both acute and acute wounds.

Antimicrobial Regenerative Wound Matrix is an extracellular matrix (ECM) based scaffolds that have very high biocompatibility properties and biodegradability features for tissue regeneration. ECM is a complex of proteins, especially collagenous forming 3D structures and allowing the incorporation of growth factors.

Among the benefits of the Antimicrobial Regenerative Wound Matrix, better ability to allow cell formation by cells, enabling its effective integration with the surrounding tissues to be repaired and also to exert antimicrobial activity. The Antimicrobial Regenerative Wound Matrix can be used as an alternative to controlling surgical infections and reducing the use of antimicrobial agents

What are the Key Trends Impacting Growth of the Antimicrobial Regenerative Wound Matrix Market?

Acute and chronic wounds, e.g. burns and diabetic ulcers, respectively, place a significant burden on patients and health care systems. An increasing number of elderly people and people with diabetes will lead to an increase in the chronic wound such as sores on the feet fuelling antimicrobial regenerative wound matrix market.

Download the Brochure@ https://www.futuremarketinsights.com/reports/brochure/rep-gb-12917

Such skin lesions are easily absorbed by the bacteria causing inflammation and this is why the healing process is challenging. Besides, the bacteria causing the infection prevent the recurrence of epithelialization and collagen synthesis. According to National Health Institute, the estimation of diabetic foot ulcers worldwide is around 6.5%.

The concept of moist wound healing, used in antimicrobial regenerative wound matrix, is now widely accepted and is associated with faster healing rates, reduced pain, better infection control, scar reduction, and lowering the cost of associated health care.

The use of skin-based ingredients offers an alternative treatment that demonstrates higher efficacy and, in some cases, a more cost-effective approach compared to traditional therapies.

Antimicrobial Regenerative Wound Matrix dressings are also widely used in wound dressing in the occurrence of road accident treatments and traumatic injuries.

An increasing prevalence worldwide in chronic ulcers such as diabetes, foot ulcers, and sharp wounds such as surgical and traumatic wounds is expected to increase in patients receiving wound care.

According to a data published by department of endocrinology of Nanjing university medical school in 2019 the prevalence of diabetic foot in North America was estimated to be 13% among diabetic patients.

The Unstoppable Rise of Antimicrobial Regenerative Wound Matrix: How a Fringe Movement Went Mainstream

The great economic and social impact of wounds in our society requires the allocation of a high level of attention and resources to understand the biological mechanisms that cause the severity of wounds.

According to a 2015 report, in Europe, as a result of ineffective treatment of such ulcers, 450,000 lower limbs each year have so far cost about € 2-2.5 billion. A U.S. figure indicates that 6.5 million patients are affected by chronic ulcers, whose annual medical expenses reach $ 25 billion. The US government spends $50 billion on wound care annually

Rise in sedentary lifestyle, chronic illnesses can lead to the development of chronic wounds and ulcers giving rise to antimicrobial regenerative wound matrix market

It is estimated that a single diabetic ulcer carries an estimated cost of US $ 50,000 and the total chronic wounds cost the medical system more than the US $ 25 billion a year, with the number of affected patients growing each year from 6.5 million, given the increasing prevalence of diabetes and other chronic disease conditions that may affect wound healing.

An increase in the elderly and an increase in chronic diseases such as diabetes will fuel the antimicrobial regenerative wound matrix market. The formation of chronic wounds such as leg ulcers, foot ulcers, and pressure ulcers can increase with aging, obesity, smoking, poor nutrition, and stress associated with diseases (e.g., AIDS) or drugs (e.g. chemotherapy or radiation therapy) are one of the few reasons giving Antimicrobial Regenerative Wound Matrix market rise in the future.

What are the Key Challenges that may Restrain Growth of the Antimicrobial Regenerative Wound Matrix Market?

Antimicrobial Regenerative Wound Matrix is considered to lie on the higher side of the price scale due to the scarce scarcity of resources and high processing costs. The high cost can especially be a cause for concern in emerging markets.

Although the overall cost effectiveness of Regenerative Wound Matrix products is lesser than traditional wound dressing. Lack of proper reimbursement for the products is one of the major restraining factors for the market, especially in developing countries. These restrain lead to the uptake of traditional wound dressing even in few developed countries.

Development of cost effective Regenerative Wound Matrix dressing product can help in expansion of the antimicrobial regenerative wound matrix market. Lack of proper information and knowledge about the Regenerative Wound Matrix products is one of the restraining factor for the market.

Competitive Landscape

Key players such as

  • 3M
  • Turn Therapeutics
  • DSM Biomedical
  • H&R Healthcare Ltd
  • Harbor Medtech Inc.
  • Smith & Nephew Plc
  • Aroa Biosurgery Ltd.
  • RenovoDerm
  •  Integra LifeSciences
  • BioLogiQ, Inc.
  • Johnson & Johnson
  • Gore Medical
  • Shire GmbH

are actively involved in offering Antimicrobial Regenerative Wound Matrix for different applications.

What strategies are the Key Players adopting for Increasing their Market Share in the Antimicrobial Regenerative Wound Matrix Market?

Key players involved in the Antimicrobial Regenerative Wound Matrix market are using strategies such as mergers and acquisitions, partnerships, and introducing new products to strengthen their position in the high-end wound dressing market.

In May 2019, 3M acquired Acelity, Inc. aiming to strengthen its wound management solutions and expand its customer base.Mergers and acquisitions have been majorly adopted and have shown great success to the key players in the expansion of Antimicrobial Regenerative Wound Matrix market share.

Rising healthcare industry in major countries in Asia will give a decent opportunity for the key players to expand the market share

What are the Key Opportunities for Antimicrobial Regenerative Wound Matrix Manufacturers?

The increase in chronic wounds due to diabetes and cancer and also increase in the elderly population have given rise to the antimicrobial regenerative wound matrix market. Also, there has been significant technological advancement in wound care management which has also become the main attraction for the antimicrobial regenerative wound matrix market.

An increase in the number of surgical procedures and acute wounds has also attracted manufacturers to invest in the antimicrobial regenerative wound matrix market. The proliferation of chronic diseases such as diabetes, cancer, and other autoimmune diseases, sedentary lifestyle, alcohol, and smoking has brought the need for Antimicrobial Regenerative Wound Matrix.

Natural polymers have been dominating the market with collagen and chitosan being the highest in demand due to their better ECM formation capability. Collagen and Silver-based products have also been great demanding compounds for the manufacturing of antimicrobial regenerative wound matrix products as silver has remained the best antimicrobial healing compound for decades.

Antimicrobial Regenerative Wound Matrix currently available in the market is usually made with hydrogels, films, sponges, and foam. As a new class of antimicrobial regenerative wound matrix, emerging ECM offers different benefits.

Antimicrobial Regenerative Wound Matrix tends to show higher altitudes thus allowing for adequate water and oxygen infiltration, as well as a higher exchange of nutrients and removal of debris.

They can provide excellent flexibility, thus being the best protection and protection against wounds. These benefits can boost the antimicrobial regenerative wound matrix market.

According to center for disease control and prevention the overall prevalence of surgical site infections caused by surgical wounds in 2018 were 2.8%. This will give a boost to the use of antimicrobial wound dressing products. Technological advancements in field of wound dressing will give rise to adoption of Antimicrobial Regenerative Wound Matrix.

Regional share of Antimicrobial Regenerative Wound Matrix

The U.S dominated the Antimicrobial Regenerative Wound Matrix market accounting for the largest revenue share. The reason involved the better healthcare services and medical infrastructure. Also the better information about wound care management and its importance.

According to National Health Institute, North America has a prevalence of diabetic foot ulcers to be 13%. This ratio is higher than in Asia where it is around 5%. Europe stands second in terms of the Antimicrobial Regenerative Wound Matrix market due to rising awareness and information about the Regenerative Wound Matrix products. Europe is expected to grow at a significant CAGR due to the awareness about the products.

Asia-Pacific holds the emerging region for the growth of the market. Factors include cheaper availability of healthcare facilities and products. Also the rising increase of knowledge of wound management and rise in income has significantly increased the per capita healthcare spending.

Expansion of the healthcare industry in china, japan, and India will give a boost to the Antimicrobial Regenerative Wound Matrix market in Asia-Pacific region

What is the Repercussion of the Pandemic on the Growth of the Antimicrobial Regenerative Wound Matrix Market?

The pandemic has greatly disrupted the Antimicrobial Regenerative Wound Matrix market. Due to coronavirus outbreaks, the flow of patients into the hospitals has been reduced which has led to the decline in the patients seeking treatments.

Also, the production industries have been largely obstructed due to lockdown causing an unprecedented technology and business model transformation. This disruption in the supply chain will hamper the production of the Antimicrobial Regenerative Wound Matrix products.

Key Segments of Antimicrobial Regenerative Wound Matrix Market Covered in the Report

Wound :

  • Acute
  • Chronic

Material:

  • Natural Polymer
    • Collagen
    • Cellulose
    • Chitosan
    • Pullulan
    • Starch
    • Β-Glucan
    • Hyaluronic Acid
    • Alginate
  • Synthetic Polymer
    • Poly Ε-Caprolactone (PCL)
    • Poly Lactic Acid (PLA)
    • Poly Lactic-Co-Glycolic Acid (PLGA)
    • Poly Vinylalcohol (PVA)

Download the TOC of this Report with figures:  https://www.futuremarketinsights.com/toc/rep-gb-12917

Region :

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot NO: JLT-PH1-l3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Remote Magnetic Catheter Systems Market Size, Share, Trend Insights By Growth, Research Methodology, Emerging Trends and Forecast to 2027

Remote Magnetic Catheter Systems has been manufactured in such a manner that enhance patient care in atrial arrhythmia diagnosis and treatment. The remote magnetic catheter systems categorized into three main parts on the basis of its functionality, In the first part two large permanent magnets that are installed on both sides of the procedure table in the electrophysiology laboratory. These magnets are used to create an external magnetic field that will direct intra-cardiac devices such as ablation catheters. Secondly, a diagnostic mapping and ablation catheter that has a small magnet embedded in its tip and the third part of the systems is a computer that allows for the user to control and direct magnetic fields. Remote magnetic catheter systems have advantages over the conventional method. In remote magnetic catheter systems, the catheter stability plays the pivotal role to convert the complex ablation procedure into simplest one. Remote magnetic catheter systems enhance the efficacy and accuracy of procedure as well as its also help to reduce chances of radiation exposure to physicians, staff and patient.Remote Magnetic Catheter Systems: Regional Overview

Based on geographic region remote magnetic catheter systems are classified into seven key regions, North, America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, Middle East and Africa. The market in North America is supposed to hold the largest share of remote magnetic catheter systems in the global market, followed by Western Europe, owing to the presence of sophisticated healthcare infrastructure, surging research and favourable reimbursement scenario. In addition to that, rising funding by both government and private sectors are also gardening the growth of remote magnetic catheter systems market. Remote magnetic catheter systems in Asia- Pacific region and Japan are anticipated to grow at a higher rate owing to the presence of large consumer base and increasing support such as funding and grants from the government sector. However, the market for remote magnetic catheter systems in regions such as Latin America, Eastern Europe, and Middle East and Africa are estimated to show a stagnant growth over the forecast period.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6055

Remote Magnetic Catheter Systems Market: Drivers and Restraint
Increasing incidence of cardiovascular disease and conditions such as diabetes, obesity, and hypertension are leading towards various hearts problems and technological advancements are major driving factors for the remote magnetic catheter systems market. Rising prevalence of atrial fibrillation in geriatric population and immense research and developments activities in the field of catheter ablation devices also propel the growth of remote magnetic catheter systems market over the forecast period. However, lack of skilled professionals and high cost of the treatment incurred by the patient, which obstruct the demands of these systems may be the factors expected to hamper growth of remote magnetic catheter systems market over the forecast period

Remote Magnetic Catheter Systems: Key Players

Some of the key market participants in the Remote Magnetic Catheter Systems are Biosense Webster stereotaxis Inc. and others. The company is involved in R&D to exploit maximum revenue potential in the global Remote Magnetic Catheter Systems Market.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6055

Remote Magnetic Catheter Systems Market: Segmentation

The global market for Remote Magnetic Catheter Systems segmented by application type, end user, and geography:

Based on the Application, Remote Magnetic Catheter Systems is segmented into following:

  • Ablation of Supraventricular tachycardia
  • Ablation of Atrial fibrillation
  • Ablation of Ventricular tachycardia
  • Coronary Interventions
  • Others

Based on the End User, Remote Magnetic Catheter Systems is segmented into following:

  • Hospital
  • Specialty clinics
  • Ambulatory surgical centers

Based on the Geography, Remote Magnetic Catheter Systems is segmented into following:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan
  • Japan
  • The Middle East and Africa

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-6055

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Anti-shock Trousers Market Size, Status, Potential Growth, Regional Analysis, Recent Trends and Forecast to 2028

Anti-shock trousers are self-contained units, which are made of one abdominal section and two leg sections attached to an inflation unit. Medical anti-shock trousers restore blood pressure, particularly the central circulation by returning blood from the lower body. The design of an anti-shock trouser makes it easy to wear for a patient, and avoids the chances of side effects due to over inflation. Pneumatic medical anti-shock trousers are widely encouraged by the hospital management for trauma victims. The device is reusable, which makes it attractive for the application in emerging economies. The device is comfortable even with prolonged use of the device at low pressures. Military anti-shock trouser is one of the most widely used medical devices in pre-hospital care. The use of trouser should be based on the type of injury as well as the type of shock.

Competition Outlook
Examples of some of the players identified in the global anti-shock trousers market are Boscarol Srl, CIR Medical, etc. Anti-shock trousers are mostly used in cardiogenic shock and during blood loss. The prime importance of the anti-shock trouser suit seems to be in the relocation of shocked patients from the place of injury to the hospital. Manufacturers are developing lightweight anti-shock trousers with various pressure variants, which can cover all the segments of the anti-shock trousers market. However, innovations to make anti-shock trouser durable and cost-effective offer a global opportunity to its manufacturers. 

Need of Anti-shock Trousers

Anti-shock trouser is an innovative product used in various medical emergency and patient care. The technology to develop anti-shock trouser was incorporated from a project done by NASA in 1970. The anti-shock trousers are very helpful in maintaining blood flow and the control the pressure shows that the patient should have major balance flow of blood during injuries. The anti-shock feature applies external counter pressure to the lower abdomen and balances the blood flow. The garments used for anti-shock trouser are of high-quality and can bear pressure for any emergency use. Anti-shock is very effective in trauma cases, which occur due to ruptured internal organ, pediatric cases and any other natural disasters. In medical emergency cases, anti-shock trousers are needed while transporting the patient to the nearest hospital.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6598

Factors Driving and Restraining the Anti-shock Trousers Market

The global market for anti-shock trousers is driven by increasing patient pool and increase in the number of trauma cases. According to the CDC (Centers for Disease Control and Prevention), TBI (Traumatic Brain Injury) is a major case in the U.S., which results in deaths of 153 people every day. Various innovations are conducted by major players to make anti-shock trousers more durable, flam proof with various other integration of digital smart devices, which is another factor driving the demand for anti-shock trousers across the globe. However, the high cost of the trousers and lack of availability of the product in various regions restrict the growth of the anti-shock trousers market.

Anti-shock trousers Market Assessment by Product Type

anti-shock-trousers-market-0.jpg

Key Data Points Covered in the Report

The report covers exhaustive analysis on:

  • Anti-shock Trousers Market by product type, application and region
  • Regional level market analysis of North America, Latin America, Europe, Asia Pacific Excluding Japan, Japan, Middle East & Africa by product type, application segments and country
  • Anti-shock Trousers Market Dynamics & Opportunity Assessment
  • Historical Actual Market Size, 2013 – 2017
  • Anti-shock Trousers Market Size & Forecast 2018 – 2028
  • Anti-shock Trousers Agents Current Trends/Issues/Challenges
  • Competition & Companies involved

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6598

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Market Segmentation 

By Product Type

  • Military Based Product
  • Medical Based Product

By Application

  • Cardiogenic Shock
  • Postural Hypotension
  • Septic Shock
  • Head Injuries

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/6598

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Atypical Antipsychotic Market Report Overview, Company Profiles, Consumption by Region, Value Chain and Sales Analysis to 2027

The increasing prevalence of lifestyle-related problems associated with mental disorders, and increasing number of bipolar disorders are booming the growth of the market from the last decade. Rising number of patients suffering from major depressive disorders, bipolar disorders, schizophrenia and other mental disorders are fueling the need for atypical antipsychotic drugs, and in turn driving the growth of the global atypical antipsychotic market.  Early prevention of the mental disorders plays an important role in minimizing the damage caused due to mental disorders.  Atypical antipsychotic drugs are available in the hospital pharmacies, e-commerce, retail pharmacies and drug stores. Atypical antipsychotics are usually prescribed to provide treatment for negative symptoms of psychosis such as hallucinations, and delusions, among others. Atypical antipsychotics produce a sedative or tranquilizing effect. Both typical and atypical antipsychotics are used to treat symptoms of schizophrenia and bipolar disorders. However, atypical antipsychotics have a broad spectrum of action than typical antipsychotics and are used to treat depressions that do not respond to antidepressant medications alone. Some of the atypical antipsychotic drugs are also used for severe anxiety, persistent hiccups, problems with balance and nausea. It can also be given in agitation and some psychotic experiences in dementia. Atypical antipsychotics are available in various dosage forms, however, the commonly prescribed dosage forms are tablets or liquids. Atypical antipsychotic drugs do not cure psychosis but can control symptoms such as delusions, hallucinations, including paranoia and hearing voices, etc. They are also helpful in conditions such as anxiety and serious agitation, for example, feeling threatened. They also cure incoherent speech, muddled thinking, confusion, violent behavior, and mania. 
Evolution of Atypical Antipsychotic DrugsThe introduction of atypical antipsychotic drugs in the market has changed the scenario of the serious mentally disorders.  Patients suffering from mental disorders are no longer needed to be physically restrained and could be managed with drug treatment and medication. The introduction of atypical antipsychotic drugs was a breakthrough in psychiatric care. Clozaril (clozapine) was the first FDA-approved atypical antipsychotic drug, which was used for the treatment of schizophrenia. Sandoz Pharmaceutical Corporation was the inventor of Clozaril drug. Clozaril is an effective drug for schizophrenia without any extrapyramidal symptoms (EPS) or side effects. According to the New York Times, Clozaril was one of the world’s most expensive drugs. Janssen Pharmaceutical division of Johnson and Johnson was the second company with another atypical antipsychotic drug called Risperdal (risperidone), which was approved by the FDA in 1993. In 2003, the drug was approved to treat bipolar disorders. The third atypical antipsychotic drug called Zyprexa (olanzapine) was launched by Eli Lily in the market. In 1996, Zyprexa was given the FDA approval after the clinical studies. Later on, many atypical antipsychotic drugs were introduced in the market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6603

Atypical Antipsychotic Market Assessment by Indication Type

atypical antipsychotic market

Atypical Antipsychotics Drugs

Some of the commonly used atypical antipsychotics drugs for the treatment of mental disorders are Ziprasidone, Paliperidone, Aripiprazole, Risperidone, Quetiapine, and others. A significant portion of the market has been covered by Quetiapine and Risperidone because they are inexpensive drugs used to treat schizophrenia and bipolar disorders. Moreover, the awareness towards mental disorders is primarily important, which leads to strong positioning of the drugs in the overall market.

Regional Market Outlook

Geographically, the global atypical antipsychotic market is segmented into seven key regions viz.  North America, Latin America, Western Europe, Eastern Europe,  Asia Pacific excluding Japan, Japan, and the Middle East & Africa. North America will continue to dominate the global market due to large patient pool and high treatment rates. Europe is expected to hold second highest share in the global atypical antipsychotic market owing to increasing R&D efforts by the key players in the region. Asia Pacific is expected to have delayed growth in the atypical antipsychotics market. According to the Medical Council of India, many Indians are diagnosed with psychological disorders but due to lack of awareness, they are being untreated.

Competition Outlook

Examples of some of the key players identified in the global atypical antipsychotic market are GlaxoSmithKline Plc., Johnson and Johnson, Pfizer Inc., Eil Lilly and Company, Bristol-Myers Squibb Company, Allergan Plc., Cardinal Health Inc., Sanis Health Inc. , Ranbaxy Inc. (Sun Pharmaceutical Industries Ltd.), Novartis AG,  etc.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6603

Small-Scale Manufacturers/Providers:

  • Ranbaxy Inc. (Sun Pharmaceutical Industries Ltd.

Medium-Scale Manufacturers/Providers

  • Cardinal Health Inc.
  • Sanis Health Inc.

Large-Scale Manufacturers/Providers

  • Bristol-Myers Squibb Company
  • Novartis AG
  • Allergan Plc.
  • GlaxoSmithKline Plc.
  • Johnson and Johnson
  • Pfizer Inc.
  • Eil Lilly and Company

 Key data points covered in report

The report covers exhaustive analysis on:

  • Atypical Antipsychotic Market by test type, end user and region
  • Regional level market analysis of North America, Latin America, Europe, Asia Pacific Excluding Japan, Japan, Middle East & Africa by test type, end user segments and country
  • Atypical Antipsychotic Market Dynamics & Opportunity Assessment
  • Historical Actual Market Size, 2013 – 2017
  • Atypical Antipsychotic Market Size & Forecast 2018 – 2028
  • Organ Function Assays Agents Current Trends/Issues/Challenges
  • Competition & Companies involved

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-6603

Market Segmentation 

By Drug Class

  • Risperidone
  • Olanzapine
  • Quetiapine
  • Ziprasidone
  • Aripiprazole
  • Paliperidone
  • Lurasidone

By Indication

  • Bipolar I Disorder
  • Schizophrenia
  • Schizoaffective Disorder
  • Major Depressive Disorder (MDD)

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Drug Store
  • E-commerce

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Folliculotropic Mycosis Fungoides Treatment Market Overview & Analysis of New Trends, Opportunities & Competitive Landscape 2022-2031

Folliculotropic Mycosis Fungoides (FMF), one type of cutaneous T-cell lymphoma is a rare disease in which white blood cells, namely lymphocytes become harmful or cancerous causing adverse effect on skin. Red patches on skin without any injury can be a sign of the disease. The disease is more prominent in males than in females with a ratio between 1.6 and 2.

Several treatments are there but they are performed based on how severe the disease is and previous medical treatments. Treatments such as Irradiation, Photochemotherapy, using ultraviolet A, light treatment enhanced with psoralen (PUVA), photodynamic therapy, carbon dioxide laser surgery are performed. Performing surgery first has its own benefit as providing radiation to the same location at a later time preserves options for future therapy.

Click on the link for Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-13012

Growing Prevalence of Radiation Therapy as a Treatment

Radiation therapy uses radiations to destroy the cancer cells. Radiation therapy can be performed to get rid of the cancerous cells entirely or to control the symptoms in severe stages. A study by Thomas et al reported that a single dose of radiation (700-800cGy) results in giving much more palliations than multiple fraction radiation treatment among patients with cutaneous T-cell lymphoma (CTCL). The International Lymphoma Radiation Oncology Group Network advices total dose of 8-12Gy to be given to patients of CTCL. According to redjournal.org, radiation therapy doses provide good clinical response and less toxicity.

Among 270 lesions on which radiation treatment was performed, 97% were treated with 700cGy of radiation. The complete response rate was among 94.4% lesions and partial response was witnessed in 3.7% of patients. Only 1 lesion showed zero response. Therefore, radiation treatment may be a good response for mycosis fungoids and thus, its demand may fuel in the treatment sector.

Effectiveness of Extracorporeal Photopheresis (ECP) may Help Grow the Folliculotropic Mycosis Fungoides Treatment Market

Many patients suffering from advanced cutaneous T-cell lymphomas may be treated by ECP. It is a painless procedure that treats the white blood cells improving the symptoms. Besides, CTCL, ECP is used for treating lung transplant rejection, heart transplant rejection, and chronic graft versus host disease. The procedure is safe and typically takes 2 hours in total. The procedure can be performed with a single piece of equipment and is easier to evaluate the quality and quantity of treated mononuclear cells. Slight side effects can be observed such as numbness or headache and eyes and skin is more sensitive to sunlight after the treatment. Moreover, ECP treatment is cost effective as compared to other treatments.

Thus, comfortable and speedy treatment plays a crucial role in encouraging the patients to adopt the procedure. Awareness regarding these treatments is another factor why the market may fuel growth.

High Cost of Treatment may Impact the Market

Chemotherapies or any other treatment for cancer is high in cost and large population of the world cannot afford that which cause deaths and may impact the Folliculotropic Mycosis Fungoides Treatment market also. For instance, an article by ncbi.nlm.nih.gov reports, phototherapy with psoralens and ultraviolet A light (PUVA) cost almost 3,187 Euros for 6 months, electron beam therapy costs around 7,913 Euros for 6 months. Also, higher incidences of the diseases are reported in Spain only.

India is also the region where a large number of population do not have health insurance and they cannot pay out of pocket medical expenses due to lack of resources. India spends only 3.89% of GDP on health care as compared to US which spends 17.8%. Thus, in developing economies, the Folliculotropic Mycosis Fungoides Treatment market may be hampered due to lack of awareness and less resources available.

Competitive Landscape

Major companies in the global Folliculotropic Mycosis Fungoides Treatment Market are

  • Astellas Pharma, Inc
  • Bayer AG
  • Novartis AG
  • Pfizer Inc
  • Merck Co., Inc.
  • GlaxoSmithKline plc
  • Abbott, Mylan N.V, etc.

Many innovations and researches are being performed to develop more painless and cost effective treatments for patients. For instance,

In July 2020, Mallinckrodt plc, a global pharmaceutical company, and Termo BCT, a global leader in blood component in Australia announced that the Medical Services Advisory Committee and Pharmaceutical Benefits Advisory Committee recommended UVADEX for extracorporeal administration with the THERAKOS CELLEX Photopheresis System. UVADEX is indicated for the treatment of the skin manifestation of CTCL and steroid refractory and steroid intolerant chronic graft versus HSC transplantation.

A research article by zaad.org, in April 2020 focuses on CADMI molecule. Based on research findings, the report states that CADMI might contribute to the pathogenesis of mycosis fungoids by inducing TCR signalling and interaction between neoplastic cells and microenvironment. Its therapeutic applications and quality of directly interacting with T-cell receptor to enhance phosphorylation, may be valuable and promising in diagnosis.

In June 2020, the 4th World Congress of Cutaneous Lymphoma suggested the use of chlormethine gel which is a topical therapy for mycosis fungoids. It is an alkylating agent which mechanism of action including cross linking of DNA in rapidly dividing cells, leading to death of the cell. The pivotel 201 study reported that the gel can be an advantage for early stage mycosis fungoides.

Regional Outlook

The demand for the Folliculotropic Mycosis Fungoides Treatment Market is increased due to many factors such as good health care infrastructure, large population suffering from cancer, increasing geriatric population, etc.

North America is expected to dominate the FMF market due to rising prevalence and awareness related to T-cell lymphoma. According to cutaneous lymphoma foundation, CTCL is a rare disease and around 3000 new cases are recorded in US each year in adult population of above 50 years specifically and FMF can be found in 16,000-20,000 of them. In US, almost 95% of population have health insurance and thus, restrain of high cost is not effective there and high class healthcare infrastructure with every latest facility is the factor for growth of the Folliculotropic Mycosis Fungoides Treatment Market.

Asia Pacific is also the leading region for the treatment as the region comprise of 60% of global population and 50% of patients suffering from different types of cancer. Lack of awareness and late diagnosis result in higher number of cancer patients in the region. Development of treatments and medications in the region, for example Takeda China in May 2020 announced their approved ADCETRIS for use in adult patients with relapsed or refractory systematic Anaplastic Large Cell Lymphoma. The development is aimed to lower the mortality rate of patients due to Hodgkin lymphoma.

According to report of Europe’s beating cancer plan published by Europa.eu, Europe is one of the leading regions for cancer population in the world with over 2.7 million people diagnosed with cancer in 2020 and over 1.3 million people lost their life due to the disease. Stringent regulations and actions have been taken by the government for its treatment, investment in research and innovation in European Union are the factors for growth for the Folliculotropic Mycosis Fungoides Treatment Market. European Digital Strategy for the treatment of cancer using powerful tools such as Artificial Intelligence, and high performance computing to help patients to securely access and share their health data in an integrated format in the electronic health records is going to be proposed in 2021 as stated in the aforementioned report. It will highly benefit every type of cancer treatment market.

Key Segments of global folliculotropic mycosis fungoides treatment market Covered in the Report

By Treatment:

  • Chemotherapy
  • Radiation Therapy
  • Immunotherapy
  • Targeted Therapy

By Drug Type:

  • Topical Steroids
  • Mechlorethamine
  • Interferons

By End-user:

  • Hospitals
  • Private Clinics
  • Specialty Clinics

Click on the link for TOC of this Report: https://www.futuremarketinsights.com/toc/rep-gb-13012

By Region:

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Europe (Germany, U.K., France, Italy, Spain, BENELUX, Poland, Russia, Nordic, Rest of Europe)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, Thailand, Malaysia, Vietnam, Indonesia)
  • Oceania (Australia, New Zealand)
  • Middle East & Africa (GCC Countries, South Africa, Rest of MEA)

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot NO: JLT-PH1-l3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Blood Processing Disposables Market Top Players with Share, Product Scope, Total Revenues, Business Development and Opportunities till 2027

Factors Driving Blood Processing Disposables

Increasing demand for blood components such as WBC, plasma, platelets, granulocytes, factor concentrates, RBC in chronic conditions is the primary factor driving the growth of the global blood processing disposables market. Rising prevalence of rare blood-related disorders and increasing number of patients suffering from chronic anemia are factors expected to enhance the demand for blood-derived components, which in turn is expected to fuel the consumption of blood processing disposables. Automation in blood processing is the major driving force for the demand for blood processing disposables. Blood processing disposables are commonly made of PVC plastic, however, toxic properties of plastic restrict their use. Some of the disadvantages of blood processing disposables are leaching of plastic materials in the product, which is expected to degrade the growth of the blood processing disposables market.

The use of disposable blood processing accessories has increased in the last few years as the majority of blood processing laboratories are adopting blood processing disposables to reduce the cleaning and sterilization cost. Blood processing disposables also reduce bacterial contamination and product discard rates by minimizing repeated contact with the blood or blood components. Blood processing disposables are available as single-processing sets or triple-processing sets. Single-processing sets consist of filters, tubing sets, cell processing bags, waste collection bags, etc. Filters are meant for separation of blood components such as plasma, leukocytes, and RBCs, among others; disposable tubing sets are used in almost every cell processing procedure. Disposable tubing sets transfer blood from the blood collection bag to the blood processing bag and waste collection bag. Disposable cell processing bags provide means to add or remove fluids during processing and contain a final product after processing is finished. The triple-processing set contains the same tubing sets as single-processing sets. However, they offer flexibility to process a larger volume of blood by using more than one cell processing bag and more ways to connect additional starting cell products and processing or washing solutions. Triple-processing sets are used for bone marrow processing.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6592

Blood Processing Disposables Market Assessment by End User

blood processing disposables market 02

Regional Market Outlook

Geographically, the global blood processing disposables market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, and the Middle East and Africa. Europe so far dominated the global blood processing disposables market in 2016 due to maximum number of CE-mark automated blood processing equipment available in the market. Some of the automated blood processing equipment, such as REVOS (Terumo BCT), are not yet commercially launched in the high growth markets of the U.S. However, the launch of this equipment in the U.S. market may render the region be dominating in the global blood processing disposables market over the forecast period.

Competition Outlook

Examples of some of the players identified in the global blood processing disposables market include TERUMO BCT, INC., HLL Lifecare Ltd., Fresenius Kabi AG, Terumo Corporation, Poly Medicure Limited, JMS Co., Ltd., Grifols SA, Mitra Industries (P) Ltd., Medline Industries, Inc., GenesisBPS, and Haemonetics Corporation, among others. Majority of companies are manufacturing blood processing disposables for particular automated blood processing systems. For instance, Terumo BCT manufactures blood processing disposables for its REVEOS system.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6592

Small-Scale Manufacturers/Providers Medium-Scale Manufacturers/Providers Large-Scale Manufacturers/Providers
  • Mitra Industries (P) Ltd.
  • Haemonetics Corporation etc.
  • JMS Co.
  • HLL Lifecare Ltd.
  • Poly Medicure Limited, JMS Co., Ltd
  • Medline Industries, Inc.
  • GenesisBPS
  • TERUMO BCT, INC.,
  • Fresenius Kabi AG
  • Terumo Corporation
  • Grifols SA
  • Haemonetics Corporation etc.

Key Data Points Covered in Report

The report covers exhaustive analysis on:

  • Blood Processing Disposables Market by product type, construction material, end user and region
  • Regional level market analysis of North America, Latin America, Europe, Asia Pacific Excluding Japan, Japan, Middle East & Africa by test type, end user segments and country
  • Blood Processing Disposables Market Dynamics & Opportunity Assessment
  • Historical Actual Market Size, 2013 – 2017
  • Blood Processing Disposables Market Size & Forecast 2018 – 2028
  • Blood Processing Disposables Market Current Trends/Issues/Challenges
  • Competition & Companies involved

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Market Segmentation 

By Product Type

  • Single-processing sets
  • Triple-processing sets
  • Disposable Blood Processing Set components (double couplers, tubing sets, luer connectors etc.)

By Construction Material

  • Polyvinylchloride (PVC) Blood Processing Disposables
  • Non-PVC Blood Processing Disposables

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-6592

By End User

  • Hospitals
  • Blood Processing Laboratories
  • Academic and Research laboratories
  • Manufacturers of Blood Products /Blood components

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Chitin Market is set to grow at 12.7% CAGR through 2027

“Chitin Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027),” a new analytical research report published by Future Market Insights covers various aspects of the global market for chitin. The report reveals analysis on end use industries using chitin for various applications. It lays emphasis on opportunities for growth in the chitin market along with key factors pushing the growth of the global market. Chitin market is categorised on the basis of derivative type, by its application in various end use industries and by region. The various facets of the global market across important geographies are monitored.

The impact of factors change from region to region thus changing the course of the chitin market in that particular region. This gives a brief idea about the market potential for chitin in various regions that key stakeholders can use to plan future expansion. The comprehensive research study portrays a realistic picture of the global chitin market by including a weighted market segmentation along with forecast projections for a period of 10 years from 2017 till 2027.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-313

 

Global Chitin Market: Competitive Scenario

The research report on the global chitin market covers analysis on various key players operating in the market. The list includes major companies such as Wellable, SHANDONG LAIZHOU HIGHLY BIO-PRODUCTS CO.Ltd., Yaizu Suisankagaku Industry Co., Ltd., Zhejiang Aoxing Biotechnology Co., Ltd., Bayir Extracts Pvt. Ltd., Golden-Shell Pharmaceutical Co. Ltd., Bio21, Panvo Organics Pvt Ltd., Tidal Vision, Primex ehf, Meron Biopolymers, Heppe Medical Chitosan GmbH, CarboMer, Inc., DALIAN XINDIE CHITIN CO.,Ltd., Kunpoong Bio Co. Ltd., Advanced Biopolymers AS and Mahtani Chitosan Pvt. Ltd.

Global Chitin Market: Growth Influencing Aspects

Increasing use in the agrochemical industry, rising shrimp waste generation, increasing awareness regarding the benefits of chitin based products in several end use industries, growing use of chitin in various applications in the healthcare industry, increasing production and consumption of chitosan and glucosamine (derivatives of chitin), and a growing use of chitosan in the beverage industry are few of the drivers that are fuelling the growth of the chitin market across the globe. However, the market is not devoid of challenges. Hindrances such as non-conformance to halal food standards, increase in pricing, low effectiveness of chitin based medicines as compared to non-chitin based medicines, high overhead costs associated with the production of chitin and adulteration are certain factors restricting the growth of the global chitin market.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-313

 

Global Chitin Market: Segmental Outlook

The global chitin market is segmented by end use industry, by derivative type and by region.

  • By region, Asia Pacific excluding Japan (APEJ) is the largest. The chitin market in the APEJ region is estimated to reach a high value of a little over US$ 1 Bn by 2027 end. This region is highly lucrative for the growth of the chitin market. Chitin market in APEJ is projected to grow at a high value CAGR of 13.9% during the forecast period.
  • By derivative type, the glucosamine segment reflects high value and is expected to reach US$ 1,840 Mn by 2027 end. The chitosan segment is expected to grow at a higher CAGR during the said period.
  • By end use industry, the healthcare segment is the largest in terms of both value and volume. This segment is projected to grow at the highest rate in the coming years to register a CAGR of 14.2% in terms of value.

Global Chitin Market: Future Market Projections

The global chitin market is expected to reach a valuation of just under US$ 2,942 Mn by the end of the assessment year in 2027 from a valuation of around US$ 893 Mn in 2017, with an exponential value CAGR of 12.7% throughout the period of forecast (2017 – 2027).

For more insights into the global chitin market, write in to Future Market Insights analysts at press@futuremarketinsights.com

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-313

Market Segmentation

The research report on global chitin market covers weighted market segmentation that covers every angle of the market.

By Derivative Type

  • Glucosamine
  • Chitosan
  • Others

By End Use Industry

  • Food and Beverages
  • Agrochemical
  • Healthcare
  • Cosmetics and Toiletries
  • Waste and Water Treatment
  • Others

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan (APEJ)
  • Japan
  • Middle East and Africa (MEA)

Chromatography Resin Market is poised to expand at a steady growth rate of around 6.90% CAGR during the forecast period of 2021 and 2031

ESOMAR-certified consulting firm Future Market Insights’ report projects the global chromatography resin market to rise at an impressive pace between 2021 and 2031. Growing adoption of affinity chromatography resin technology is expected to increase the demand of chromatography resins across the globe. Alongside this, increase in demand for monoclonal antibody production will improve the sales over the coming years.

Demand for chromatography resins is rising extensively within the biopharmaceutical companies and research institutes. Burgeoning adoption of synthetic chromatography resin for the separation of biosimilars and development of monoclonal antibodies will spur the growth.

As per the FMI’s analysis, affinity chromatography resin sales are set to grow at over 11.3% CAGR, to surpass a valuation of approx. US$ 879.6 Mn by 2031-end. However, stringent regulatory policies, availability of cost-effective alternatives, and high cost of the chromatography technologies are some of the factors limiting the market growth.

Increasing funding by governments and initiatives undertaken to curb the mortality rate due to non-communicable diseases will spur the adoption of chromatography resins across the globe. Also, increasing expenditure on the research & development of drug delivery among the industry giants will also boost the market demand.

According to the FMI’s analysis, the global chromatography resins market is anticipated to reach a valuation of nearly US$ 2215 Mn, registering a steady growth at 6.90% CAGR between 2021 and 2031.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1349

chromatography resin market characteristics and attributes with regional relevence, 2021-2031

Key Takeaways from FMI’s Chromatography Resin Market Study

  • In terms of product type, synthetic chromatography resins are anticipated to witness higher growth compared to the native chromatography resins
  • Affinity chromatography resin technology is expected to lead the segment, exhibiting the growth at 11.3% CAGR
  • Biopharmaceutical companies will remain the largest end-users of chromatography resins across the globe, surpassing valuation of approx. US$ 900 Mn by 2031-end
  • Rising government initiatives to curb the non-communicable diseases across India will spur the market demand
  • The U.S. is expected to remain the largest market of chromatography resins throughout the forecast period
  • Germany and the U.K, collectively, will lead the Europe’s chromatography resin market owing to the rising prevalence of non-communicable disease
  • China is anticipated to emerge as a potential market on the back of rising adoption of advanced chromatography technologies within the region

“Increasing research & development activities aimed at the development of economic monoclonal antibody drugs within the biopharmaceutical companies are expected to provide lucrative opportunities for the market players,” says the FMI analyst. 

Competitive LandscapeAgilent Technologies, Bio-Rad Laboratories Inc., GE Healthcare, Waters Corporation, Expedeon Ltd., Thermo Fisher Scientific Inc., Pall Corporation, Merck KGaA, PerkinElmer Inc., Kaneka Corporation, Shimadzu Corporation, Knauer GmbH, Tosoch Bioscience, Avantor Performance Materials Inc., Mitsubishi Chemical Corporation, W.R. Grace & Co., JSR Micro Inc., and Life Technology Corporation among others are some key players operating in the chromatography resin market.

As per the FMI’s analysis, the market is dominated by top 5 players in the global chromatography resin market, accounting for over 70% of market share. Top 5 players include Bio-Rad Laboratories, Inc., GE Healthcare, Tosoh Corporation, Merck KGaA, and Thermo Fisher Scientific Inc.

Market players operating in chromatography resins market are also forming tie-ups and targeted mergers & collaboration with other top healthcare companies for the expansion of their product portfolios.

For instance, in February 2021, Repligen Corporation, a global life sciences company focused on bioprocessing technology leadership, and Navigo Proteins GmbH, a prominent protein engineering company specializing in novel affinity ligand development, announced the commercial launch of NGL COVID-19 Spike Protein Affinity Resin, a novel affinity resin used in the purification of COVID-19 vaccines.

On February 4th, 2021 Avitide, another leading player, finalized the development of an affinity bioprocess resin, AVIPure-COV2S, for the purification of recombinant COVID-19 vaccines.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1349

More Insights on the Global Chromatography Resin MarketIn its latest report, FMI provides an incisive coverage on the global chromatography resin market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (native and synthetic), technology type (affinity chromatography, anion exchange chromatography, cation exchange chromatography, size exclusion, and hydrophobic interaction), end user type (biopharmaceutical companies, clinical research organizations, and academic institutes), and across major regions (North America, Latin America, Eastern Europe, Asia Pacific excluding Japan, Western Europe, Japan and Middle East & Africa)

Chromatography Resin Market by CategoryBy Product Type:

  • Native
  • Synthetic

By Technology Type:

  • Affinity Chromatography
  • Anion Exchange Chromatography
  • Cation Exchange Chromatography
  • Size Exclusion
  • Hydrophobic Interaction

By End User Type:

  • Biopharmaceutical Companies
  • Clinical Research Organizations
  • Academic Institutes

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Point-of-care Cholesterol Monitoring Device Market is expected to reach US$ 514.7 Million by 2028

[250 Pages Report] FMI Analyses Key Pull Factors Translating into the Sluggish Revenue Growth of Point of Care Cholesterol Monitoring Device Market

Recently in 2017, FDA approved the SD LipidoCare System launched by SD Biosensor Inc. However, a majority of medical device manufacturers continue to face the challenges to new product launch as a set of certain evolved amendments recently designed by regulatory policies target the lack of standardization across their device portfolios. Local medical device manufacturers exclusively encounter the impediments posed by regulatory-linked issues.

More importantly, the inaccuracy of results delivered by point of care cholesterol monitoring devices still persists that makes the entire procedure less reliable and riskier. This continues to linger as a major concern restraining revenue growth of point of care cholesterol monitoring device market.

A new Future Market Insights’ study on the global sales scenario for point of care cholesterol monitoring devices projects just-under 2.6% year over year revenue growth for the market estimated to cross US$ 428.8 Mn in 2021.

Increasing CVD prevalence and a growing number of high-cholesterol cases are sustaining the demand for point of care cholesterol monitoring device worldwide. Although a growing patient population is maintaining a decent consumption rate of point of care cholesterol monitoring devices, high per test cost and tightening regulatory norms regarding medical devices launch continue to limit adoption.

point of care cholesterol monitoring device market

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-7773

Global Point of Care Cholesterol Monitoring Device Market Taxonomy: By Product Type, Technology Type, Application Type, End User, and Region

  • According to the product type analysis of point of care cholesterol monitoring device market presented in the report, testing kits are currently more popular but instruments, especially computerized, are gradually gaining ground among end users and thus end use segments.
  • The technology type analysis of point of care cholesterol monitoring device market reveals that both the key technologies, i.e. electrochemical biosensor and reflectance photometry currently hold an almost equal share of the market revenue. The overall growth is however sluggish.
  • Based on the application type analysis, the point of care cholesterol monitoring device market is likely to witness maximum demand for atherosclerosis patients, whereas sales of point of care cholesterol monitoring devices in the hypercholesterolemia segment is also considerable.
  • End user analysis offered in the point of care cholesterol monitoring device market report uncovers considerable product consumption by diagnostic centers, diagnostic laboratories, hospitals, and ambulatory surgical centers. Lucrative adoption prospects for point of care cholesterol monitoring devices have been indicated in home care settings.
  • While more than 1/3rd of the global market revenue belongs to North America, Western Europe and APECJ remain the next two key markets for point of care cholesterol monitoring devices. The report forecasts attractive product innovation and penetration opportunities arising in MEA and Latin America for manufacturers.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-7773

A Growing Self-testing Trend Boosts Point of Care Cholesterol Monitoring Device Demand in Home Care SettingsThe point of care cholesterol monitoring device market is currently witnessing a rapid consumer shift to self-testing at home. While home testing of cholesterol level is highly convenient, it also offers the result in a matter of a few minutes. Patients are increasingly aware about the significance of early risk detection that further helps prevention of complications related to the level of cholesterol and thereby heart conditions.

The demand for point of care cholesterol monitoring devices in home care settings is thus witnessing a gradual surge in recent years, and the FMI study points to a higher yearly growth in the revenue of devices designed for home testing.

Key Manufacturing Trends Spotted in Point of Care Cholesterol Monitoring Device Market

  • Advanced technology integration
  • Devices with a portability feature
  • Convenient applicability for home testing

Besides these prominent trends, leading industry manufacturers are investing in strategic acquisitions for a broader approach to the businesses opportunities in global landscape. Moreover, companies are concentrating on product innovation and value chain expansion with an intent to achieve enhanced market positions.

  • Abbott’s acquisition of Alere Inc. has been helping the former securing a leading position in the point of care testing space, as the company through this deal expanded its global diagnostics portfolio.
  • The recent M&A deal between Abaxis Inc. and Zoetis intends to broaden the manufacturing and marketing scope of point of care veterinary diagnostic instruments.
  • ACON Laboratories, Inc. targets the international customer base with the recently released Mission Lipid Data Management Software.

Point-of-care Cholesterol Monitoring Device Market by CategoryBy Product

  • Instruments
    • Table-top Analyzers
    • Hand-held Analyzers
  • Testing Kits

By Technology

  • Electrochemical Biosensor
  • Reflectance Photometry

By Application

  • Dyslipidemia
  • Atherosclerosis
  • Hypercholestrolemia
  • Hypocholesterolimea
  • Others

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/7773

By End User

  • Hospitals
  • Diagnostics centers & Laboratory
  • Ambulatory surgical centers
  • Home care sittings

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Peripheral Vascular Stents Market is expected to attain a net worth of US$ 5.3 Billion by 2028

[263 Pages Report] According to the latest market report published by Future Market Insights, titled ‘Peripheral Vascular Stents Market: Global Industry Analysis 2013 – 2021 and Opportunity Assessment 2022 – 2028’, the global peripheral vascular stents market is expected to expand at a CAGR of 6.6% over the forecast period 2022–2028.

FMI estimates that the global market for peripheral vascular stents is to be valued at US$ 2,822.5 Mn in 2022 and is expected to expand at CAGR of 6.6% over 2022–2028, to reach US$ 5,324.1 Mn by 2028 end. Based on product type, the self-expanding stents segment dominated the global peripheral vascular stents market, with over 52.1% value share in 2021. The segment is expected to grow at above 6.6% CAGR over the forecast period.North America is expected to maintain its dominance in the global market due to regulatory approval of several new products such as drug eluting stents in the U.S., Europe and Japan. Increasing awareness of peripheral surgeries and prevalence of peripheral artery disease in developing countries such as India and Brazil remains the major factor driving the demand for peripheral vascular stents. Increasing in number end users and growing number of ambulatory surgical centres are the other major factors expected to drive the growth of the global peripheral vascular stents market.

An intravascular stent is a synthetic tubular mesh structure used for permanent implant in graft or native vasculature. A stent is basically designed to provide mechanical radial support after assigning; the support is meant to improve vessel patency over the life of the device. After the stent is placed in the intended location, it is expanded by a balloon or self-expanding mechanism.

peripheral vascular stents market

Global Peripheral Vascular Stents Market: Segmental ForecastThe global peripheral vascular stents market has been segmented on the basis of product type, artery type, end user and regions. Globally, the self-expanding stents is expected to be the most attractive segment from the manufacturers’ point of view. Although there is a high demand for drug eluting stents and the segment leads in terms of market volume in the forecast period, high price of drug eluting stents would lead to low revenue contribution of the product type segment. Among all the artery types, high demand of peripheral stents is expected to come from iliac artery segment due to growing prevalence for peripheral artery disease in many countries across the globe.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2091

Global Peripheral Vascular Stents Market: Regional AnalysisIn terms of value, the global peripheral vascular stents market is expected to expand at 6.6% CAGR over the forecast period of 2022–2028. With nearly 48.5% market share, North America dominated in the global peripheral vascular stents market in 2021, partly due to penetration of newly approved drug eluting stents in the U.S. Western Europe is expected to be the second large market globally, with the U.K., Italy, France and Germany being countries with high growth rates. APEJ is expected to be the second large market for peripheral vascular stents, primarily due to improving immunization access and availability of cost-effective surgeries.

Global Peripheral Vascular Stents Market: Competition TrackingThe market for peripheral vascular stents is consolidated with few players contributing over 55% of revenue share. The key players identified in the global market include Medtronic Plc., Becton, Dickinson and Company, Cardinal Health, Inc., B. Braun Melsungen AG, MicroPort Scientific Corporation, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Abbott Laboratories, W.L. Gore & Associates Inc., and Cook Medical Inc., among others. Acquisition of established products to gain immediate growth is the key strategy adopted by key players in the market.

Key Segments Covered Peripheral Vascular Stents Industry SurveyPeripheral Vascular Stents Market by Product Type

  • Self-Expanding Stents
  • Balloon-Expanding Stents
  • Covered Stents
  • Drug-Eluting Stents

Peripheral Vascular Stents Market by Artery Type

  • Carotid Artery
  • Fem-Pop Artery
  • Iliac Artery
  • Infrapop Artery

Peripheral Vascular Stents Market by End User

  • Hospitals
  • Ambulatory Surgical Centers/Outpatients

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2091

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/